In addition, this study offers insight into the underlying mechanisms of the disease, including the regulation of hepatic adiponectin and FXR activity, by which AO extract ameliorates NAFLD. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.